Aprobarbital
From Wikipedia, the free encyclopedia
| Systematic (IUPAC) name | |
|---|---|
| 5-propan-2-yl- 5-prop-2-enyl- 1,3-diazinane- 2,4,6-trione | |
| Clinical data | |
| AHFS/Drugs.com | Micromedex Detailed Consumer Information |
| Pregnancy cat. | ? |
| Legal status | ? |
| Identifiers | |
| CAS number | 77-02-1 |
| ATC code | N05CA05 |
| PubChem | CID 6464 |
| DrugBank | DB01352 |
| ChemSpider | 6221 |
| UNII | Q0YKG9L6RF |
| KEGG | D00698 |
| ChEBI | CHEBI:2791 |
| ChEMBL | CHEMBL7863 |
| Synonyms | Aprobarbital, Oramon, Allylpropymal, Alurate, 5-Isopropyl- 5-allylbarbituric acid |
| Chemical data | |
| Formula | C10H14N2O3 |
| Mol. mass | 210.23 g/mol |
| SMILES | eMolecules & PubChem |
|
|
| |
Aprobarbital (as known in the United States, or aprobarbitone (as known elsewhere), sold as Oramon, Somnifaine, and Allonal, is a barbiturate derivative invented in the 1920s by Ernst Preiswerk. It has sedative, hypnotic and anticonvulsant properties, and was used primarily for the treatment of insomnia. [1] Aprobarbital was never as widely used as more common barbiturate derivatives such as phenobarbital and is now rarely prescribed as it has been replaced by newer drugs with a better safety margin.
[edit] References
- ^ Reddemann H, Turk E. Oramon poisoning in infancy and childhood. Observations on 12 aprobarbital poisonings (German). Das Deutsche Gesundheitswesen. 1966 May 12;21(19):878-81.
|
| This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it. |

